Breast Cancer

Patients with early-stage triple-negative breast cancer who did not have circulating tumor DNA in their blood experienced superior outcomes to chemotherapy followed by surgery.

Whether we have cancer or not, gratitude enriches our lives and there are many things to be grateful for.

Residual cancer burden can help physicians pinpoint accurate long-term predictions about the likelihood that a patient’s breast cancer will return.

Women who took estrogen alone as hormone therapy for their menopause experienced decreased rates of breast cancer and death from the disease even after they stopped taking the therapy, when compared to women who took estrogen with progestin.

Survival and recurrence rates were similar among patients with breast cancer who either received accelerated partial breast irradiation or whole breast irradiation.

This massive event for women with breast cancer just may be “man’s breast friend”.

Women treated with Arimidex for five years were 50% less likely to have developed breast cancer recurrence compared with women given placebo at nearly 11 years follow-up after stopping treatment.

Adding Tecentriq to chemotherapy before surgery did not improve the rate of pathologic complete response in patients with advanced, early-stage triple-negative breast cancer.

Nearly 65% of patients whose disease had spread to lymph nodes showed no signs of cancer following a regimen of Keytruda plus chemotherapy compared with those who received chemotherapy alone.

Results from a phase 3 trial showed significant increases in five-year invasive disease-free survival estimates among Japanese patients with hormone receptor-positive, HER2-negative breast cancer.

Researchers found that the addition of Perjeta to Herceptin plus chemotherapy reduced the relative risk for breast cancer recurrence or death in patients with operable HER2-positive early breast cancer, according to a six-year follow-up.

The HER2-targeted antibody-drug conjugate T-DXd achieved a response in 60.9% of patients, according to phase 2 study findings.

The label of being a cancer survivor can be simple, but underneath it can mean something so different to each person. Only you can choose what the idea of survivorship means to your journey.

Something I have often done when approaching a problem or setback in life is to find a success story that helps to motivate me and inspire me along my own journey.

Choosing a gift for the person with cancer can be challenging. In this post, survivor Bonnie Annis offers some helpful information by sharing thoughts as she remembers her own past Christmases.

Rebuilding your life after a kick in the gut is all about your mindset.

"I’ve been out on a limb for the past eight years. I can tell you firsthand, it gets lonely out there… and scary."

Here are the top five CURE® stories for November 2019.

"When diagnosed with breast cancer, it helped for me to reflect daily upon my gratitude list as a way to overcome adversity."

One survivor accepts her nontraditional meal this year and embraces cancer’s lessons.

Keeping traditions “normal” while facing cancer can wear patients down.

When senior citizens gather to discuss our latest medical interventions, procedures and replacement parts - there's just one way to describe it.

Know your cancer before making a treatment decision.

The art of camouflage can be important for the breast cancer survivor choosing not to reconstruct.

Clinical genetics experts see value in testing more women for BRCA mutations.